The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Cardiovascular and Renal Drugs Advisory Committee. This meeting was announced in the Federal Register of February 27, 2015 (80 FR 10700). The amendment is being made to reflect a change in the Agenda portion of the document. There are no other changes.
Document
Cardiovascular and Renal Drugs Advisory Committee; Amendment of Notice
The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Cardiovascular and Renal Drugs Advisory Committee. This meeting was announced i...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
80 FR 14139
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Cardiovascular and Renal Drugs Advisory Committee; Amendment of Notice,” thefederalregister.org (March 18, 2015), https://thefederalregister.org/documents/2015-06130/cardiovascular-and-renal-drugs-advisory-committee-amendment-of-notice.